AstraZeneca and YMCA target the overlooked barriers delaying cancer screening in America
AstraZeneca is funding a five-year YMCA cancer initiative that will begin in 75 communities, but its impact will depend on whether education leads to completed screenings, clinical referrals and sustained survivor support.